Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Pinpoint root causes, such as leakage or overspending, then implement targeted adjustments to regain monthly balance.
23,777 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Automakers report record truck profits even as they book a roughly $7 billion charge tied to exiting certain EV progr...
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
House Democrats unveiled a pair of bills aimed at banning event contracts on Polymarket US and other platforms. The m...
China’s DeepSeek AI forecasts upside for XRP, Bitcoin and Ethereum through 2026, citing improving on-chain data and a...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...
This article offers a fresh, investor-focused look at american outdoor brands (aout) earnings. It breaks down revenue...
Traders are turning toward three mid-cap miners as the tape says these growth stocks could ride higher metal prices a...
Washington eyes a softer Basel III endgame, freeing up about $175B in excess bank capital. Crypto markets are watchin...
A sharp rise in crypto ATM scams drove hundreds of millions in losses in 2025, as criminals exploited quick cash-to-c...
The housing muni market swells as affordability policy debates unfold, fueling a surge in bond issuance to fund low-c...
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...